Physician profile
Evan Peskin
NPI 1669904959
$71,920.18
in general payments reported to CMS, 2019-2025
22 companies · $52K in 2025
The $52K reported for 2025 was more than what 98% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,233 · 2022: $2,195 · 2023: $3,394 · 2024: $13K · 2025: $52K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $53K · Food and Beverage: $8,825 · Travel and Lodging: $6,777 · Gift: $15.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $52,875.00 |
| Food and Beverage | $8,824.69 |
| Travel and Lodging | $6,777.45 |
| Gift | $15.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nalu Medical, INC. | $57,157.05 | 2021-2025 | Nalu Neurostimulation System |
| Saluda Medical Americas, INC. | $2,228.41 | 2023-2025 | Evoke, Evoke Scs |
| Medtronic, INC. | $2,014.57 | 2021-2024 | Synchromedii |
| Boston Scientific Corporation | $1,895.80 | 2021-2025 | General - Pain Management, Intracept |
| Abbott Laboratories | $1,738.93 | 2022-2024 | Proclaim, Eterna |
| Genesys Orthopedics Systems, L.L.C. | $1,433.46 | 2024 | Sacroiliac Joint Fusion System |
| Nevro Corp. | $1,353.19 | 2023-2024 | Senza |
| Stryker Corporation | $1,029.72 | 2024 | Optablate, Spinejack |
| Relievant Medsystems, INC. | $1,019.27 | 2023 | Intracept |
| Globus Medical, INC. | $808.32 | 2025 | Senza, Corridor, Vyrsa V1 |
| Painteq LLC | $205.15 | 2023-2024 | Painteq |
| Averitas Pharma INC. | $174.65 | 2023-2024 | Qutenza |
| Abbvie INC. | $167.16 | 2023-2025 | |
| Vertos Medical, INC. | $144.24 | 2024 | Mild Device Kit |
| Spinal Simplicity, LLC | $142.57 | 2025 | Ha Minuteman G3-R |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mml US, INC. | $134.80 | 2022 | |
| Stimwave Technologies Incorporated | $82.61 | 2022 | |
| Si-Bone, INC. | $72.99 | 2025 | |
| Spr Therapeutics, INC | $52.00 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $26.40 | 2024 | Cuvitru |
| Scilex Pharmaceuticals INC. | $24.98 | 2024 | |
| Forte Bio-Pharma LLC | $13.91 | 2025 | Prolate, Nalocet, Tanlor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evan Peskin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.